These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 43030)

  • 1. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-adrenergic blocking agents ATP and anabolic hormones in the treatment of ischemic heart disease].
    Smolenskiĭ VS; Abinder AA
    Sov Med; 1977 Jan; (1):44-8. PubMed ID: 15321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience in treatment of patients with ischemic heart disease by means of beta adrenergic blocking agents].
    Lebedev SV
    Klin Med (Mosk); 1977 May; 55(5):54-7. PubMed ID: 17769
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of metabolically active agents in ischemic heart disease patients].
    Denisiuk VI
    Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of coronary insufficiency with beta receptor blocking agents].
    Wink K
    Med Monatsschr; 1975 Feb; 29(2):65-7. PubMed ID: 236488
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
    Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM
    Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of milurite in ischemic heart disease].
    Teslenko VG; Khimenko LP
    Vrach Delo; 1980 Oct; (10):18-21. PubMed ID: 7434694
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention].
    Pedersen A
    Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of beta-blocking agents in diagnosis and therapy of coronary insufficiency].
    Binaghi G; Giani P; Rizzato GF; Mortarino G; Bruno L; Bandera L; Folli G
    Mal Cardiovasc; 1969; 10(4):811-25. PubMed ID: 4397279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
    Andrushchenko EV; Chmir VP; Krasovskaia EA; Malanchuk TA; Polishchuk II; Iashchenko OB
    Vrach Delo; 1990 Nov; (11):35-8. PubMed ID: 1983050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of patients with chronic coronary insufficiency].
    Miasnikov LA; Metelitsa VI
    Kardiologiia; 1972 Jul; 12(7):144-55. PubMed ID: 4133504
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adrenergic beta blocking agents in clinical medicine: hopes and disappointments].
    Cosma M
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(4):992-4. PubMed ID: 4156087
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
    Agapova EN; Tkachenko AM; Krutovskaia OV
    Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E
    Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.